|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||
|
||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s3C4D49EA-5E9D-11EF-9989-036085CE164B&I=39IZM&T=&OP=Display&O=html&O1=15662888&O2=2660000000039941&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DPhysiology%252C%2520pharmacology%2520and%2520prospects%2520for%2520dipeptidilpeptidase-4%2520inhibitors%2520use%26rft.au%3DBakulin%252C%2520D.%2520A.%26rft.au%3DKurkin%252C%2520D.%2520V.%26rft.au%3DMorkovin%252C%2520E.%2520I.%26rft.au%3DStrygin%252C%2520A.%2520V.%26rft.date%3D2023-01-01%26rft.eissn%3D2413-2241%26rft.epage%3D47%26rft.externalDBID%3Dn%252Fa%26rft.externalDocID%3D10_19163_2307_9266_2023_11_1_19_47%26rft.genre%3Darticle%26rft.issn%3D2307-9266%26rft.issue%3D1%26rft.jtitle%3DFarmaci%25C3%25A2%2520i%2520Farmakologi%25C3%25A2%2520%2528P%25C3%25A2tigorsk%2529%26rft.spage%3D19%26rft.volume%3D11%26rft_id%3Dinfo%253Adoi%252F10.19163%252F2307-9266-2023-11-1-19-47%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-DOAJ_DIRECTORY_OPEN_ACCESS_JOURNALS-getFullTxt-object,2-EZB-FREE-00999_FREELY_AVAILABLE_EZB_JOURNALS-getFullTxt-object,3-DOI-getDOI-object,4-COBIB_SI_LCL-getHolding-object,5-REFWORKS_EXPORT_TOOL-getReference-object,6-GOOGLE_SCHOLAR_FREE-getWebSearch-object,7-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.245725&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15662888-s3C4D49EA-5E9D-11EF-9989-036085CE164B" timestamp="2024-08-20T04:38:18Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:2660000000039941</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Physiology, pharmacology and prospects for dipeptidilpeptidase-4 inhibitors use</jnl:atitle>
<jnl:jtitle>Farmaciâ i Farmakologiâ (Pâtigorsk)</jnl:jtitle>
<jnl:date>2023-05-01</jnl:date>
<jnl:spage>19</jnl:spage>
<jnl:epage>47</jnl:epage>
<jnl:issn>2307-9266</jnl:issn>
<jnl:volume>11</jnl:volume>
<jnl:issue>1</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2413-2241</jnl:eissn>
<jnl:language>rus</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:e237e7a83c46c82bb7245974da7f587c73559c9c</ctx:identifier>
<ctx:identifier>urn:UUID:s3C4D49EA-5E9D-11EF-9989-036085CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)